Monique Lagacé

Author PubWeight™ 9.95^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting.	J Biol Chem	2004	2.03
2	Pharmacological chaperones: potential treatment for conformational diseases.	Trends Endocrinol Metab	2004	1.96
3	Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties.	J Biol Chem	2004	1.39
4	Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059.	Mol Endocrinol	2004	1.04
5	Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling.	Mol Pharmacol	2006	0.99
6	Combining resonance energy transfer methods reveals a complex between the alpha2A-adrenergic receptor, Galphai1beta1gamma2, and GRK2.	FASEB J	2010	0.87
7	Protein-protein interactions monitored in cells from transgenic mice using bioluminescence resonance energy transfer.	FASEB J	2010	0.87
8	The gene product of the gp78/AMFR ubiquitin E3 ligase cDNA is selectively recognized by the 3F3A antibody within a subdomain of the endoplasmic reticulum.	Biochem Biophys Res Commun	2004	0.80